Bioactivity, Health Benefits, and Related Molecular Mechanisms of Curcumin: Current Progress, Challenges, and Perspectives

Xiao-Yu Xu, Xiao Meng, Sha Li, Ren-You Gan, Ya Li, Hua-Bin Li, Xiao-Yu Xu, Xiao Meng, Sha Li, Ren-You Gan, Ya Li, Hua-Bin Li

Abstract

Curcumin is a principal curcuminoid of turmeric (Curcuma longa), which is commonly used as a spice in cooking and a yellow pigment in the food processing industry. Recent studies have demonstrated that curcumin has a variety of biological activities and pharmacological performances, providing protection and promotion of human health. In addition to presenting an overview of the gut metabolism of curcumin, this paper reviews the current research progress on its versatile bioactivity, such as antioxidant, anti-inflammatory, and immune-regulatory activities, and also intensively discusses its health benefits, including the protective or preventive effects on cancers and diabetes, as well as the liver, nervous system, and cardiovascular systems, highlighting the potential molecular mechanisms. Besides, the beneficial effects of curcumin on human are further stated based on clinical trials. Considering that there is still a debate on the beneficial effects of curcumin, we also discuss related challenges and prospects. Overall, curcumin is a promising ingredient of novel functional foods, with protective efficacy in preventing certain diseases. We hope this comprehensive and updated review will be helpful for promoting human-based studies to facilitate its use in human health and diseases in the future.

Keywords: anti-inflammatory; anticancer; antioxidant; curcumin; gut metabolism; health benefits; molecular mechanisms.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Three major curcuminoids in turmeric and their chemical structures.
Figure 2
Figure 2
Metabolic pathways of curcumin. Oral administration mainly metabolizes curcumin into conjugated curcumin, while intravenous or intraperitoneal administration mainly leads to reduced curcumin. In addition, minor free and intact curcumin can be detected in plasma after any administration.
Figure 3
Figure 3
The signaling pathways involved in the anti-inflammation action of curcumin. The up arrows indicate the activation, while the down arrows indicate the inhibition. The treatment with curcumin induces the protection of S-nitrosylation on IKKβ, phosphorylation-IκB, and binding with MD2. The suppression of NF-κB activation and the increase of HO-1 activity contribute to the reduction of inflammation. HO-1, Heme oxygenase-1; IKKβ, Inhibitor of NF-κB kinase subunit β; IκB, Inhibitor of NF-κB; MD2, Myeloid differentiation protein 2; NF-κB, Nuclear factor κB; TLR4, Toll-like receptor 4; TLR4-MD2, Myeloid differentiation protein 2-TLR 4 co-receptor.
Figure 4
Figure 4
Curcumin-mediated anticancer signaling pathways, associated with the induction of apoptosis and cell cycle arrest, as well as the inhibition of angiogenesis. The up arrows indicate the upregulation, while the down arrows indicate the downregulation. Bcl-2, B-cell lymphoma 2; Bcl-xL, B-cell lymphoma-extra large; Bik, Bcl-2-interacting killer; Bim, Bcl-2 interacting mediator of cell death; Bax, Bcl-2-associated X protein; Bak, Bcl-2 homologous antagonist killer; SERCA, Sarco/endoplasmic reticulum calcium ATPase; PARP, Poly (ADP-ribose) polymerase; Ras, an oncogene product in many human cancers; ERK1/2, Extracellular signal-regulated kinases; Akt, Protein kinase B; mTOR, Mammalian target of rapamycin; S6K1, p70-S6 kinase 1; EGFR, Epidermal growth factor receptor; VEGF, Vascular endothelial growth factor; COX-2, Cyclooxygenase-2.
Figure 5
Figure 5
A summary of the bioactivity and health benefits of curcumin, including antioxidant, anti-inflammatory, immune-regulatory, anticancer, neuroprotective, hepatoprotective, cardiovascular protective, and anti-diabetic effects.

References

    1. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: A short review. Life Sci. 2006;78:2081–2087. doi: 10.1016/j.lfs.2005.12.007.
    1. Nelson K.M., Dahlin J.L., Bisson J., Graham J., Pauli G.F., Walters M.A. The essential medicinal chemistry of curcumin. J. Med. Chem. 2017;60:1620–1637. doi: 10.1021/acs.jmedchem.6b00975.
    1. Awasthi M., Singh S., Pandey V.P., Dwivedi U.N. Curcumin: Structure-activity relationship towards its role as a versatile multi-targeted therapeutics. Mini Rev. Org. Chem. 2017;14:311–332. doi: 10.2174/1570193X14666170518112446.
    1. Wang R., Li J.B., Zhao Y.L., Li Y.P., Yin L. Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis. Breast Cancer. 2018;25:206–212. doi: 10.1007/s12282-017-0816-6.
    1. Cao J., Wang T., Wang M. Investigation of the anti-cataractogenic mechanisms of curcumin through in vivo and in vitro studies. BMC Ophthalmol. 2018;18:48. doi: 10.1186/s12886-018-0711-8.
    1. Pulido-Moran M., Moreno-Fernandez J., Ramirez-Tortosa C., Ramirez-Tortosa M.C. Curcumin and health. Molecules. 2016;21:264. doi: 10.3390/molecules21030264.
    1. Jankun J., Wyganowska-Swiatkowska M., Dettlaff K., Jelinska A., Surdacka A., Watrobska-Swietlikowska D., Skrzypczak-Jankun E. Determining whether curcumin degradation/condensation is actually bioactivation (review) Int. J. Mol. Med. 2016;37:1151–1158. doi: 10.3892/ijmm.2016.2524.
    1. Holder G.M., Plummer J.L., Ryan A.J. The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica. 1978;8:761–768. doi: 10.3109/00498257809069589.
    1. Asai A., Miyazawa T. Occurrence of orally administered curcuminoid as glucuronide and glucuronide/sulfate conjugates in rat plasma. Life Sci. 2000;67:2785–2793. doi: 10.1016/S0024-3205(00)00868-7.
    1. Hoehle S.I., Pfeiffer E., Metzler M. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases. Mol. Nutr. Food Res. 2007;51:932–938. doi: 10.1002/mnfr.200600283.
    1. Prasad S., Tyagi A.K., Aggarwal B.B. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Res. Treat. 2014;46:2–18. doi: 10.4143/crt.2014.46.1.2.
    1. Tsuda T. Curcumin as a functional food-derived factor: Degradation products, metabolites, bioactivity, and future perspectives. Food Funct. 2018;9:705–714. doi: 10.1039/C7FO01242J.
    1. Hoehle S.I., Pfeiffer E., Solyom A.M., Metzler M. Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J. Agric. Food Chem. 2006;54:756–764. doi: 10.1021/jf058146a.
    1. Pfeiffer E., Hoehle S.I., Walch S.G., Riess A., Solyom A.M., Metzler M. Curcuminoids form reactive glucuronides in vitro. J. Agric. Food Chem. 2007;55:538–544. doi: 10.1021/jf0623283.
    1. Huang Y.Y., Cao S.J., Zhang Q., Zhang H.Y., Fan Y.Q., Qiu F., Kang N. Biological and pharmacological effects of hexahydrocurcumin, a metabolite of curcumin. Arch. Biochem. Biophys. 2018;646:31–37. doi: 10.1016/j.abb.2018.03.030.
    1. Dempe J.S., Scheerle R.K., Pfeiffer E., Metzler M. Metabolism and permeability of curcumin in cultured Caco-2 cells. Mol. Nutr. Food Res. 2013;57:1543–1549. doi: 10.1002/mnfr.201200113.
    1. Metzler M., Pfeiffer E., Schulz S.I., Dempe J.S. Curcumin uptake and metabolism. BioFactors. 2013;39:14–20. doi: 10.1002/biof.1042.
    1. Dempe J.S., Pfeiffer E., Grimm A.S., Metzler M. Metabolism of curcumin and induction of mitotic catastrophe in human cancer cells. Mol. Nutr. Food Res. 2008;52:1074–1081. doi: 10.1002/mnfr.200800029.
    1. De Oliveira M.R., Jardim F.R., Setzer W.N., Nabavi S.M., Nabavi S.F. Curcumin, mitochondrial biogenesis, and mitophagy: Exploring recent data and indicating future needs. Biotechnol. Adv. 2016;34:813–826. doi: 10.1016/j.biotechadv.2016.04.004.
    1. Lou Y., Zheng J., Hu H., Lee J., Zeng S. Application of ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry to identify curcumin metabolites produced by human intestinal bacteria. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2015;985:38–47. doi: 10.1016/j.jchromb.2015.01.014.
    1. An C.-Y., Sun Z.-Z., Shen L., Ji H.-F. Biotransformation of food spice curcumin by gut bacterium Bacillus megaterium DCMB-002 and its pharmacological implications. Food Nutr. Res. 2017;61 doi: 10.1080/16546628.2017.1412814.
    1. Burapan S., Kim M., Han J. Curcuminoid demethylation as an alternative metabolism by human intestinal microbiota. J. Agric. Food Chem. 2017;65:3306–3311. doi: 10.1021/acs.jafc.7b00943.
    1. Asouri M., Ataee R., Ahmadi A.A., Amini A., Moshaei M.R. Antioxidant and free radical scavenging activities of curcumin. Asian J. Chem. 2013;25:7593–7595.
    1. Derochette S., Franck T., Mouithys-Mickalad A., Ceusters J., Deby-Dupont G., Lejeune J.P., Neven P., Serteyn D. Curcumin and resveratrol act by different ways on NADPH oxidase activity and reactive oxygen species produced by equine neutrophils. Chem.-Biol. Interact. 2013;206:186–193. doi: 10.1016/j.cbi.2013.09.011.
    1. Zheng Q.T., Yang Z.H., Yu L.Y., Ren Y.Y., Huang Q.X., Liu Q., Ma X.Y., Chen Z.K., Wang Z.B., Zheng X. Synthesis and antioxidant activity of curcumin analogs. J. Asian Nat. Prod. Res. 2017;19:489–503. doi: 10.1080/10286020.2016.1235562.
    1. Dikmen M., Kaya-Tilki E., Engur S., Ozturk Y. Neuritogenic activity of epigallocatechin gallate and curcumin combination on rat adrenal pheochromocytoma cells. Fresenius Environ. Bull. 2017;26:4726–4733.
    1. Tapia E., Sanchez-Lozada L.G., Garcia-Nino W.R., Garcia E., Cerecedo A., Garcia-Arroyo F.E., Osorio H., Arellano A., Cristobal-Garcia M., Loredo M.L., et al. Curcumin prevents maleate-induced nephrotoxicity: Relation to hemodynamic alterations, oxidative stress, mitochondrial oxygen consumption and activity of respiratory complex I. Free Radic. Res. 2014;48:1342–1354. doi: 10.3109/10715762.2014.954109.
    1. Dai J., Gu L., Su Y., Wang Q., Zhao Y., Chen X., Deng H., Li W., Wang G., Li K. Inhibition of curcumin on influenza a virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/jnk mapk and NF-κB pathways. Int. Immunopharmacol. 2018;54:177–187. doi: 10.1016/j.intimp.2017.11.009.
    1. Dai C.S., Tang S.S., Li D.W., Zhao K.N., Xiao X.L. Curcumin attenuates quinocetone-induced oxidative stress and genotoxicity in human hepatocyte l02 cells. Toxicol. Mech. Methods. 2015;25:340–346. doi: 10.3109/15376516.2015.1045659.
    1. Maugeri A., Mazzone M.G., Giuliano F., Vinciguerra M., Basile G., Barchitta M., Agodi A. Curcumin modulates DNA methyltransferase functions in a cellular model of diabetic retinopathy. Oxid. Med. Cell. Longev. 2018;2018:5407482. doi: 10.1155/2018/5407482.
    1. Singh P., Rizvi S.I. Role of curcumin in modulating plasma PON1 arylesterase activity and susceptibility to LDL oxidation in oxidatively challenged Wistar rats. Lett. Drug Des. Discov. 2015;12:319–323. doi: 10.2174/1570180811666141016000539.
    1. Joshi D., Mittal D.K., Shukla S., Srivastav S.K., Dixit V.A. Curcuma longa Linn. Extract and curcumin protect CYP 2E1 enzymatic activity against mercuric chloride-induced hepatotoxicity and oxidative stress: A protective approach. Exp. Toxicol. Pathol. 2017;69:373–382. doi: 10.1016/j.etp.2017.02.009.
    1. El-Bahr S.M. Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin b1. Phytother. Res. 2015;29:134–140. doi: 10.1002/ptr.5239.
    1. Goc Z., Semla M., Kapusta E., Gren A., Muchacka R., Lukacova J. The effect of curcumin on the activity of antioxidant enzymes in the liver, pancreas and kidneys of Swiss mice; Proceedings of the 12th International Scientific Conference on Animal Physiology; Boretice, Czech Republic. 13–15 June 2016.
    1. Altintoprak N., Kar M., Acar M., Berkoz M., Muluk N.B., Cingi C. Antioxidant activities of curcumin in allergic rhinitis. Eur. Arch. Otorhinolaryngol. 2016;273:3765–3773. doi: 10.1007/s00405-016-4076-4.
    1. Singh P., Kesharwani R.K., Misra K., Rizvi S.I. Modulation of erythrocyte plasma membrane redox system activity by curcumin. Biochem. Res. Int. 2016;2016:6025245. doi: 10.1155/2016/6025245.
    1. Xu D.P., Li Y., Meng X., Zhou T., Zhou Y., Zheng J., Zhang J.J., Li H.B. Natural antioxidants in foods and medicinal plants: Extraction, assessment and resources. Int. J. Mol. Sci. 2017;18:96. doi: 10.3390/ijms18010096.
    1. Pompella A., Sies H., Wacker R., Brouns F., Grune T., Biesalski H.K., Frank J. The use of total antioxidant capacity as surrogate marker for food quality and its effect on health is to be discouraged. Nutrition. 2014;30:791–793. doi: 10.1016/j.nut.2013.12.002.
    1. Wang J., Wang H.Y., Zhu R.R., Liu Q., Fei J., Wang S.L. Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1 beta transgenic mice subjected to the, lipopolysaccharide-induced sepsis. Biomaterials. 2015;53:475–483. doi: 10.1016/j.biomaterials.2015.02.116.
    1. Antoine F., Girard D. Curcumin increases gelatinase activity in human neutrophils by a p38 mitogen-activated protein kinase (MAPK)-independent mechanism. J. Immunotoxicol. 2015;12:188–193. doi: 10.3109/1547691X.2014.917749.
    1. Li H.Y., Yang M., Li Z., Meng Z. Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-gamma activity and reducing oxidative stress. Int. J. Mol. Med. 2017;39:1307–1316. doi: 10.3892/ijmm.2017.2924.
    1. Zhang Y.L., Liu Z.G., Wu J.Z., Bai B., Chen H.J., Xiao Z.X., Chen L.F., Zhao Y.J., Lum H., Wang Y., et al. New MD2 inhibitors derived from curcumin with improved anti-inflammatory activity. Eur. J. Med. Chem. 2018;148:291–305. doi: 10.1016/j.ejmech.2018.02.008.
    1. Wu N.C., Wang J.J. Curcumin attenuates liver warm ischemia and reperfusion-induced combined restrictive and obstructive lung disease by reducing matrix metalloprotease 9 activity. Transplant. Proc. 2014;46:1135–1138. doi: 10.1016/j.transproceed.2013.12.020.
    1. Ferreira V.H., Nazli A., Dizzell S.E., Mueller K., Kaushic C. The anti-inflammatory activity of curcumin protects the genital mucosal epithelial barrier from disruption and blocks replication of HIV-1 and HSV-2. PLoS ONE. 2015;10:e0124903. doi: 10.1371/journal.pone.0124903.
    1. Kloesch B., Gober L., Loebsch S., Vcelar B., Helson L., Steiner G. In vitro study of a liposomal curcumin formulation (lipocurc (TM)): Toxicity and biological activity in synovial fibroblasts and macrophages. In Vivo. 2016;30:413–419.
    1. Esatbeyoglu T., Ulbrich K., Rehberg C., Rohn S., Rimbach G. Thermal stability, antioxidant, and anti-inflammatory activity of curcumin and its degradation product 4-vinyl guaiacol. Food Funct. 2015;6:887–893. doi: 10.1039/C4FO00790E.
    1. Song Z.L., Revelo X., Shao W.J., Tian L.L., Zeng K.J., Lei H., Sun H.S., Woo M., Winer D., Jin T. Dietary curcumin intervention targets mouse white adipose tissue inflammation and brown adipose tissue ucp1 expression. Obesity. 2018;26:547–558. doi: 10.1002/oby.22110.
    1. Hui-Yin Y., Ahmad N., Azmi N., Makmor-Bakry M. Curcumin: The molecular mechanisms of action in inflammation and cell death during kainate-induced epileptogenesis. Indian J. Pharm. Educ. 2018;52:32–41. doi: 10.5530/ijper.52.1.4.
    1. Wang J., Kang Y.X., Pan W., Lei W., Feng B., Wang X.J. Enhancement of anti-inflammatory activity of curcumin using phosphatidylserine-containing nanoparticles in cultured macrophages. Int. J. Mol. Sci. 2016;17:969. doi: 10.3390/ijms17060969.
    1. Hunter C.J., De Plaen I.G. Inflammatory signaling in nec: Role of NF-kappab, cytokines and other inflammatory mediators. Pathophysiol. 2014;21:55–65. doi: 10.1016/j.pathophys.2013.11.010.
    1. Kao N.J., Hu J.Y., Wu C.S., Kong Z.L. Curcumin represses the activity of inhibitor-kappa b kinase in dextran sulfate sodium-induced colitis by S-nitrosylation. Int. Immunopharmacol. 2016;38:1–7. doi: 10.1016/j.intimp.2016.05.015.
    1. Dai C.S., Ciccotosto G.D., Cappai R., Tang S.S., Li D.W., Xie S.L., Xiao X.L., Velkov T. Curcumin attenuates colistin-induced neurotoxicity in N2a cells via anti-inflammatory activity, suppression of oxidative stress, and apoptosis. Mol. Neurobiol. 2018;55:421–434. doi: 10.1007/s12035-016-0276-6.
    1. Cheng F., Chen Y.H., Zhan Z., Liu Y., Hu P., Ren H., Tang H.D., Peng M.L. Curc-MPEG454, a pegylated curcumin derivative, improves anti-inflammatory and antioxidant activities: A comparative study. Inflammation. 2018;41:579–594. doi: 10.1007/s10753-017-0714-2.
    1. Liu W.F., Li Y.L., Yue Y., Zhang K., Chen Q., Wang H.Q., Lu Y.J., Huang M.T., Zheng X., Du Z.Y. Synthesis and biological evaluation of curcumin derivatives containing NSAIDs for their anti-inflammatory activity. Bioorg. Med. Chem. Lett. 2015;25:3044–3051. doi: 10.1016/j.bmcl.2015.04.077.
    1. Wang Z.S., Chen L.Z., Zhou H.P., Liu X.H., Chen F.H. Diarylpentadienone derivatives (curcumin analogues): Synthesis and anti-inflammatory activity. Bioorg. Med. Chem. Lett. 2017;27:1803–1807. doi: 10.1016/j.bmcl.2017.02.056.
    1. Yang H.X., Du Z.Y., Wang W.C., Song M.Y., Sanidad K., Sukamtoh E., Zheng J., Tian L., Xiao H., Liu Z.H., et al. Structure-activity relationship of curcumin: Role of the methoxy group in anti-inflammatory and anticolitis effects of curcumin. J. Agric. Food Chem. 2017;65:4509–4515. doi: 10.1021/acs.jafc.7b01792.
    1. Abdollahi E., Momtazi A.A., Johnston T.P., Sahebkar A. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? J. Cell. Physiol. 2018;233:830–848. doi: 10.1002/jcp.25778.
    1. Shakeri F., Boskabady M.H. Anti-inflammatory, antioxidant, and immunomodulatory effects of curcumin in ovalbumin-sensitized rat. BioFactors. 2017;43:567–576. doi: 10.1002/biof.1364.
    1. Han F., Luo B., Shi R., Han C., Zhang Z., Xiong J., Jiang M., Zhang Z. Curcumin ameliorates rat experimental autoimmune neuritis. J. Neurosci. Res. 2014;92:743–750. doi: 10.1002/jnr.23357.
    1. Yang Z., He C.M., He J.Y., Chu J., Liu H.P., Deng X.Y. Curcumin-mediated bone marrow mesenchymal stem cell sheets create a favorable immune microenvironment for adult full-thickness cutaneous wound healing. Stem Cell. Res. Ther. 2018;9:21. doi: 10.1186/s13287-018-0768-6.
    1. Afia M., Alshehri M., Alfaifi M., Shakor A.B.A. Repressive effect of curcumin against 2-amino-3-methylimidazo 4, 5-f quinoline induced hepato- and immunotoxicity in mice. Indian J. Exp. Biol. 2017;55:365–371.
    1. Wang S., Li H., Zhang M., Yue L.T., Wang C.C., Zhang P., Liu Y., Duan R.S. Curcumin ameliorates experimental autoimmune myasthenia gravis by diverse immune cells. Neurosci. Lett. 2016;626:25–34. doi: 10.1016/j.neulet.2016.05.020.
    1. Liu Y., Chen L.Y., Shen Y., Tan T., Xie N.Z., Luo M., Li Z.H., Xie X.Y. Curcumin ameliorates ischemia-induced limb injury through immunomodulation. Med. Sci. Monit. 2016;22:2035–2042. doi: 10.12659/MSM.896217.
    1. Kumar A., Sasmal D., Jadav S.S., Sharma N. Mechanism of immunoprotective effects of curcumin in DLM-induced thymic apoptosis and altered immune function: An in silico and in vitro study. Immunopharmacol. Immunotoxicol. 2015;37:488–498. doi: 10.3109/08923973.2015.1091004.
    1. Bose S., Panda A.K., Mukherjee S., Sa G. Curcumin and tumor immune-editing: Resurrecting the immune system. Cell Div. 2015;10:6. doi: 10.1186/s13008-015-0012-z.
    1. Mahmoud H.K., Al-Sagheer A.A., Reda F.M., Mahgoub S.A., Ayyat M.S. Dietary curcumin supplement influence on growth, immunity, antioxidant status, and resistance to aeromonas hydrophila in oreochromis niloticus. Aquaculture. 2017;475:16–23. doi: 10.1016/j.aquaculture.2017.03.043.
    1. Xun W.J., Shi L.G., Zhou H.L., Hou G.Y., Cao T., Zhao C.P. Effects of curcumin on growth performance, jejunal mucosal membrane integrity, morphology and immune status in weaned piglets challenged with enterotoxigenic Escherichia coli. Int. Immunopharmacol. 2015;27:46–52. doi: 10.1016/j.intimp.2015.04.038.
    1. Lee G., Chung H.S., Lee K., Lee H., Kim M., Bae H. Curcumin attenuates the scurfy-induced immune disorder, a model of ipex syndrome, with inhibiting Th1/Th2/Th17 responses in mice. Phytomedicine. 2017;33:1–6. doi: 10.1016/j.phymed.2017.01.008.
    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2017. CA. Cancer J. Clin. 2017;67:7–30. doi: 10.3322/caac.21387.
    1. Liu F.R., Gao S., Yang Y.X., Zhao X.D., Fan Y.M., Ma W.X., Yang D.R., Yang A.M., Yu Y. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Oncol. Rep. 2018;39:1523–1531. doi: 10.3892/or.2018.6188.
    1. Carroll R.E., Benya R.V., Turgeon D.K., Vareed S., Neuman M., Rodriguez L., Kakarala M., Carpenter P.M., McLaren C., Meyskens F.L., Jr., et al. Phase II a clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev. Res. 2011;4:354–364. doi: 10.1158/1940-6207.CAPR-10-0098.
    1. Feng S.Y., Wang Y., Zhang R.K., Yang G.W., Liang Z.B., Wang Z.W., Zhang G.H. Curcumin exerts its antitumor activity through regulation of miR-7/Skp2/p21 in nasopharyngeal carcinoma cells. Onco Targets Ther. 2017;10:2377–2388. doi: 10.2147/OTT.S130055.
    1. Xi Y., Gao H., Callaghan M.U., Fribley A.M., Garshott D.M., Xu Z.X., Zeng Q.H., Li Y.L. Induction of Bcl2-interacting killer, Bik, is mediated for anti-cancer activity of curcumin in human head and neck squamous cell carcinoma cells. J. Cancer. 2015;6:327–332. doi: 10.7150/jca.11185.
    1. Yoysungnoen-Chintana P., Bhattarakosol P., Patumraj S. Antitumor and antiangiogenic activities of curcumin in cervical cancer xenografts in nude mice. BioMed Res. Int. 2014;10:817972. doi: 10.1155/2014/817972.
    1. Zhan Y.Z., Chen Y.N., Liu R., Zhang H., Zhang Y.M. Potentiation of paclitaxel activity by curcumin in human breast cancer cell by modulating apoptosis and inhibiting EGFR signaling. Arch. Pharm. Res. 2014;37:1086–1095. doi: 10.1007/s12272-013-0311-3.
    1. Montgomery A., Adeyeni T., San K., Heuertz R.M., Ezekiel U.R. Curcumin sensitizes silymarin to exert synergistic anticancer activity in colon cancer cells. J. Cancer. 2016;7:1250–1257. doi: 10.7150/jca.15690.
    1. Zhou X.X., Su J.N., Feng S.Y., Wang L.X., Yin X.Y., Yan J.Z., Wang Z.W. Antitumor activity of curcumin is involved in down-regulation of YAP/TAZ expression in pancreatic cancer cells. Oncotarget. 2016;7:79062–79074. doi: 10.18632/oncotarget.12596.
    1. Kumar P., Barua C.C., Sulakhiya K., Sharma R.K. Curcumin ameliorates cisplatin-induced nephrotoxicity and potentiates its anticancer activity in SD rats: Potential role of curcumin in breast cancer chemotherapy. Front. Pharmacol. 2017;8:132. doi: 10.3389/fphar.2017.00132.
    1. Goncalves V.D., Ortega A.A.C., Guimaraes M.R., Curylofo F.A., Rossa C., Ribeiro D.A., Spolidorio L.C. Chemopreventive activity of systemically administered curcumin on oral cancer in the 4-nitroquinoline 1-oxide model. J. Cell. Biochem. 2015;116:787–796. doi: 10.1002/jcb.25035.
    1. Hosseini S., Chamani J., Rahimi H., Azmoodeh N., Ghasemi F., Abadi P.H. An in vitro study on curcumin delivery by nano-micelles for esophageal squamous cell carcinoma (KYSE-30) Rep. Biochem. Mol. Biol. 2018;6:137–143.
    1. Meena R., Kumar S., Kumar R., Gaharwar U.S., Rajamani P. Plga-ctab curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells) Biomed. Pharmacother. 2017;94:944–954. doi: 10.1016/j.biopha.2017.07.151.
    1. Francis A.P., Murthy P.B., Devasena T. Bis-demethoxy curcumin analog nanoparticles: Synthesis, characterization, and anticancer activity in vitro. J. Nanosci. Nanotechnol. 2014;14:4865–4873. doi: 10.1166/jnn.2014.9219.
    1. Ono M., Higuchi T., Takeshima M., Chen C., Nakano S. Differential anti-tumor activities of curcumin against Ras- and SRC-activated human adenocarcinoma cells. Biochem. Biophys. Res. Commun. 2013;436:186–191. doi: 10.1016/j.bbrc.2013.05.071.
    1. Rana C., Piplani H., Vaish V., Nehru B., Sanyal S.N. Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer. Tumor Biol. 2015;36:5999–6010. doi: 10.1007/s13277-015-3276-7.
    1. Choudhury D., Ganguli A., Dastidar D.G., Acharya B.R., Das A., Chakrabarti G. Apigenin shows synergistic anticancer activity with curcumin by binding at different sites of tubulin. Biochimie. 2013;95:1297–1309. doi: 10.1016/j.biochi.2013.02.010.
    1. Gao X., Wang B.L., Wu Q.J., Wei X.W., Zheng F.J., Men K., Shi H.S., Huang N., Wei Y.Q., Gong C.Y. Combined delivery and anti-cancer activity of paclitaxel and curcumin using polymeric micelles. J. Biomed. Nanotechnol. 2015;11:578–589. doi: 10.1166/jbn.2015.1964.
    1. Zhang J.M., Li J.J., Shi Z., Yang Y., Xie X., Lee S.M., Wang Y.T., Leong K.W., Chen M.W. Ph-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Acta Biomater. 2017;58:349–364. doi: 10.1016/j.actbio.2017.04.029.
    1. Mahmud M., Piwoni A., Filiczak N., Janicka M., Gubernator J. Long-circulating curcumin-loaded liposome formulations with high incorporation efficiency, stability and anticancer activity towards pancreatic adenocarcinoma cell lines in vitro. PLoS ONE. 2016;11:e0167787. doi: 10.1371/journal.pone.0167787.
    1. Ono M., Higuchi T., Takeshima M., Chen C., Nakano S. Antiproliferative and apoptosis-inducing activity of curcumin against human gallbladder adenocarcinoma cells. Anticancer Res. 2013;33:1861–1866.
    1. Sahu B.P., Hazarika H., Bharadwaj R., Loying P., Baishya R., Dash S., Das M.K. Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity. Expert Opin. Drug Deliv. 2016;13:1065–1074. doi: 10.1080/17425247.2016.1182486.
    1. Koohpar Z.K., Entezari M., Movafagh A., Hashemi M. Anticancer activity of curcumin on human breast adenocarcinoma: Role of mcl-1 gene. Iran J. Cancer Prev. 2015;8:e2331. doi: 10.17795/ijcp2331.
    1. Seo J.A., Kim B., Dhanasekaran D.N., Tsang B.K., Song Y.S. Curcumin induces apoptosis by inhibiting sarco/endoplasmic reticulum Ca2+ ATPase activity in ovarian cancer cells. Cancer Lett. 2016;371:30–37. doi: 10.1016/j.canlet.2015.11.021.
    1. Lee J.S., Wang T.S., Lin M.C., Lin W.W., Yang J.J. Inhibition of curcumin on ZAK alpha activity resultant in apoptosis and anchorage-independent growth in cancer cells. Chin. J. Physiol. 2017;60:267–274. doi: 10.4077/CJP.2017.BAG514.
    1. He Z.-Y., Shi C.-B., Wen H., Li F.-L., Wang B.-L., Wang J. Upregulation of p53 expression in patients with colorectal cancer by administration of curcumin. Cancer Investig. 2011;29:208–213. doi: 10.3109/07357907.2010.550592.
    1. Yang C.H., Yue J.M., Sims M., Pfeffer L.M. The curcumin analog EF24 targets NF-kappa B and miRNA-21, and has potent anticancer activity in vitro and in vivo. PLoS ONE. 2013;8:e71130. doi: 10.1371/journal.pone.0071130.
    1. Zhang W., Bai W., Zhang W. Mir-21 suppresses the anticancer activities of curcumin by targeting pten gene in human non-small cell lung cancer A549 cells. Clin. Transl. Oncol. 2014;16:708–713. doi: 10.1007/s12094-013-1135-9.
    1. Khan M.N., Haggag Y.A., Lane M.E., McCarron P.A., Tambuwala M.M. Polymeric nano-encapsulation of curcumin enhances its anti-cancer activity in breast (MDA-MB231) and lung (A549) cancer cells through reduction in expression of HIF-1 alpha and nuclear p65 (Rel A) Curr. Drug Deliv. 2018;15:286–295. doi: 10.2174/1567201814666171019104002.
    1. Balakrishna A., Kumar M.H. Evaluation of synergetic anticancer activity of berberine and curcumin on different models of A549, Hep-G2, MCF-7, Jurkat, and K562 cell lines. BioMed Res. Int. 2015;2015:354614. doi: 10.1155/2015/354614.
    1. Park B.H., Lim J.E., Jeon H.G., Seo S.I., Lee H.M., Choi H.Y., Jeon S.S., Jeong B.C. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. Oncotarget. 2016;7:63870–63886. doi: 10.18632/oncotarget.11563.
    1. Orr W.S., Denbo J.W., Saab K.R., Ng C.Y., Wu J.R., Li K., Garner J.M., Morton C.L., Du Z.Y., Pfeffer L.M., et al. Curcumin potentiates rhabdomyosarcoma radiosensitivity by suppressing NF-kappa B activity. PLoS ONE. 2013;8:e51309. doi: 10.1371/journal.pone.0051309.
    1. Shakibaei M., Kraehe P., Popper B., Shayan P., Goel A., Buhrmann C. Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer. BMC Cancer. 2015;15:250. doi: 10.1186/s12885-015-1291-0.
    1. Zhang P., Lai Z.L., Chen H.F., Zhang M., Wang A., Jia T., Sun W.Q., Zhu X.M., Chen X.F., Zhao Z., et al. Curcumin synergizes with 5-fluorouracil by impairing AMPK/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice. J. Exp. Clin. Cancer Res. 2017;36:190. doi: 10.1186/s13046-017-0661-7.
    1. Senft C., Polacin M., Priester M., Seifert V., Koegel D., Weissenberger J. The nontoxic natural compound curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas. BMC Cancer. 2010;10:491. doi: 10.1186/1471-2407-10-491.
    1. Deng Y., Verron E., Rohanizadeh R. Molecular mechanisms of anti-metastatic activity of curcumin. Anticancer Res. 2016;36:5639–5647. doi: 10.21873/anticanres.11147.
    1. Li S.L., Fang C.S., Zhang J.Q., Liu B.L., Wei Z.Q., Fan X.Q., Sui Z., Tan Q.Y. Catanionic lipid nanosystems improve pharmacokinetics and anti-lung cancer activity of curcumin. Nanomedicine. 2016;12:1567–1579. doi: 10.1016/j.nano.2016.02.007.
    1. Zhang W.L., Cui T., Liu L., Wu Q.J., Sun L., Li L., Wang N., Gong C.Y. Improving anti-tumor activity of curcumin by polymeric micelles in thermosensitive hydrogel system in colorectal peritoneal carcinomatosis model. J. Biomed. Nanotechnol. 2015;11:1173–1182. doi: 10.1166/jbn.2015.2073.
    1. Zheng J., Zhou Y., Li Y., Xu D.P., Li S., Li H.B. Spices for prevention and treatment of cancers. Nutrients. 2016;8:495. doi: 10.3390/nu8080495.
    1. Zhou Y., Zheng J., Li Y., Xu D.P., Li S., Chen Y.M., Li H.B. Natural polyphenols for prevention and treatment of cancer. Nutrients. 2016;8:515. doi: 10.3390/nu8080515.
    1. Abd-Allah G.A., El-Bakry K.A., Bahnasawy M.H., El-Khodary E.R. Protective effects of curcumin and ginger on liver cirrhosis induced by carbon tetrachloride in rats. Int. J. Pharmacol. 2016;12:361–369. doi: 10.3923/ijp.2016.361.369.
    1. Nabavi S.F., Daglia M., Moghaddam A.H., Habtemariam S., Nabavi S.M. Curcumin and liver disease: From chemistry to medicine. Compr. Rev. Food Sci. Food Saf. 2014;13:62–77. doi: 10.1111/1541-4337.12047.
    1. Peng X.Y., Dai C.S., Liu Q.W., Li J.K., Qiu J.R. Curcumin attenuates on carbon tetrachloride-induced acute liver injury in mice via modulation of the Nrf2/HO-1 and TGF-1/Smad3 pathway. Molecules. 2018;23:215. doi: 10.3390/molecules23010215.
    1. Choudhury S.T., Das N., Ghosh S., Ghosh D., Chakraborty S., Ali N. Vesicular (liposomal and nanoparticulated) delivery of curcumin: A comparative study on carbon tetrachloride-mediated oxidative hepatocellular damage in rat model. Int. J. Nanomed. 2016;11:2179–2193. doi: 10.2147/ijn.s101886.
    1. Tung B.T., Hai N.T., Son P.K. Hepatoprotective effect of phytosome curcumin against paracetamol-induced liver toxicity in mice. Braz. J. Pharm. Sci. 2017;53 doi: 10.1590/s2175-97902017000116136.
    1. Lee H.Y., Kim S.W., Lee G.H., Choi M.K., Jung H.W., Kim Y.J., Kwon H.J., Chae H.J. Turmeric extract and its active compound, curcumin, protect against chronic CCl4-induced liver damage by enhancing antioxidation. BMC Complement. Altern. Med. 2016;16:316. doi: 10.1186/s12906-016-1307-6.
    1. Bayindir N., Esrefoglu M., Kumas M., Iraz M., Kesgin S., Kilic E. Protective effect of curcumin on cadmium-induced liver apoptosis in rats. Bezmialem Sci. 2016;4:99–105. doi: 10.14235/bs.2016.714.
    1. Afrin R., Arumugam S., Soetikno V., Thandavarayan R.A., Pitchaimani V., Karuppagounder V., Sreedhar R., Harima M., Suzuki H., Miyashita S., et al. Curcumin ameliorates streptozotocin-induced liver damage through modulation of endoplasmic reticulum stress-mediated apoptosis in diabetic rats. Free Radic. Res. 2015;49:279–289. doi: 10.3109/10715762.2014.999674.
    1. Granados-Castro L.F., Rodriguez-Rangel D.S., Fernandez-Rojas B., Leon-Contreras J.C., Hernandez-Pando R., Medina-Campos O.N., Eugenio-Perez D., Pinzon E., Pedraza-Chaverri J. Curcumin prevents paracetamol-induced liver mitochondrial alterations. J. Pharm. Pharmacol. 2016;68:245–256. doi: 10.1111/jphp.12501.
    1. Guo C., Ma J.F., Zhong Q.H., Zhao M.Y., Hu T.X., Chen T., Qiu L.X., Wen L.P. Curcumin improves alcoholic fatty liver by inhibiting fatty acid biosynthesis. Toxicol. Appl. Pharmacol. 2017;328:1–9. doi: 10.1016/j.taap.2017.05.001.
    1. Lu C.F., Xu W.X., Zhang F., Shao J.J., Zheng S.Z. Nrf2 knockdown disrupts the protective effect of curcumin on alcohol-induced hepatocyte necroptosis. Mol. Pharm. 2016;13:4043–4053. doi: 10.1021/acs.molpharmaceut.6b00562.
    1. Buzzetti E., Pinzani M., Tsochatzis E.A. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) Metab. Clin. Exp. 2016;65:1038–1048. doi: 10.1016/j.metabol.2015.12.012.
    1. Zabihi N.A., Pirro M., Johnston T.P., Sahebkar A. Is there a role for curcumin supplementation in the treatment of non-alcoholic fatty liver disease? The data suggest yes. Curr. Pharm. Des. 2017;23:969–982. doi: 10.2174/1381612822666161010115235.
    1. Inzaugarat M.E., De Matteo E., Baz P., Lucero D., Garcia C.C., Ballerga E.G., Daruich J., Sorda J.A., Wald M.R., Chernavsky A.C. New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans. PLoS ONE. 2017;12:e0172900. doi: 10.1371/journal.pone.0172900.
    1. Watanabe K., Karuppagounder V., Arumugam S., Thandavarayan R.A., Pitchaimani V., Sreedhar R., Afrin R., Harima M., Suzuki H., Suzuki K., et al. Pruni cortex ameliorates skin inflammation possibly through HMGB1-NF kappa B pathway in house dust mite induced atopic dermatitis NC/NGA transgenic mice. J. Clin. Biochem. Nutr. 2015;56:186–194. doi: 10.3164/jcbn.14-75.
    1. Afrin R., Arumugam S., Rahman A., Wahed M.I.I., Karuppagounder V., Harima M., Suzuki H., Miyashita S., Suzuki K., Yoneyama H., et al. Curcumin ameliorates liver damage and progression of nash in NASH-HCC mouse model possibly by modulating HMGB1-Nf-kappa B translocation. Int. Immunopharmacol. 2017;44:174–182. doi: 10.1016/j.intimp.2017.01.016.
    1. Kheradpezhouh E., Barritt G.J., Rychkov G.Y. Curcumin inhibits activation of TRPM2 channels in rat hepatocytes. Redox Biol. 2016;7:1–7. doi: 10.1016/j.redox.2015.11.001.
    1. Chen N.Z., Geng Q.Q., Zheng J.B., He S., Huo X.W., Sun X.J. Suppression of the TGF-beta/Smad signaling pathway and inhibition of hepatic stellate cell proliferation play a role in the hepatoprotective effects of curcumin against alcohol-induced hepatic fibrosis. Int. J. Mol. Med. 2014;34:1110–1116. doi: 10.3892/ijmm.2014.1867.
    1. Zhang Z.L., Guo Y., Zhang S., Zhang Y., Wang Y.Q., Ni W.X., Kong D.S., Chen W.J., Zheng S.Z. Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro. Eur. J. Pharmacol. 2013;721:133–140. doi: 10.1016/j.ejphar.2013.09.042.
    1. Zhang F., Zhang Z.L., Chen L., Kong D.S., Zhang X.P., Lu C.F., Lu Y., Zheng S.Z. Curcumin attenuates angiogenesis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells. J. Cell. Mol. Med. 2014;18:1392–1406. doi: 10.1111/jcmm.12286.
    1. Zheng J.J., Wu C.Z., Lin Z., Guo Y., Shi L., Dong P.H., Lu Z.Q., Gao S.M., Liao Y., Chen B.C., et al. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation—A novel mechanism suppressing liver fibrosis. FEBS J. 2014;281:88–103. doi: 10.1111/febs.12574.
    1. Fu X.Y., Yang M.F., Cao M.Z., Li D.W., Yang X.Y., Sun J.Y., Zhang Z.Y., Mao L.L., Zhang S., Wang F.Z., et al. Strategy to suppress oxidative damage-induced neurotoxicity in PC12 cells by curcumin: The role of ROS-mediated DNA damage and the MAPK and Akt pathways. Mol. Neurobiol. 2016;53:369–378. doi: 10.1007/s12035-014-9021-1.
    1. Szczepanowicz K., Jantas D., Piotrowski M., Staron J., Leskiewicz M., Regulska M., Lason W., Warszynski P. Encapsulation of curcumin in polyelectrolyte nanocapsules and their neuroprotective activity. Nanotechnology. 2016;27:355101. doi: 10.1088/0957-4484/27/35/355101.
    1. Jin M.L., Park S.Y., Shen Q., Lai Y.H., Ou X.M., Mao Z., Lin D.X., Yu Y.Y., Zhang W.Z. Anti-neuroinflammatory effect of curcumin on Pam3CSK4-stimulated microglial cells. Int. J. Mol. Med. 2018;41:521–530. doi: 10.3892/ijmm.2017.3217.
    1. Kodali M., Hattiangady B., Shetty G.A., Bates A., Shuai B., Shetty A.K. Curcumin treatment leads to better cognitive and mood function in a model of Gulf War Illness with enhanced neurogenesis, and alleviation of inflammation and mitochondrial dysfunction in the hippocampus. Brain Behav. Immun. 2018;69:499–514. doi: 10.1016/j.bbi.2018.01.009.
    1. Tegenge M.A., Rajbhandari L., Shrestha S., Mithal A., Hosmane S., Venkatesan A. Curcumin protects axons from degeneration in the setting of local neuroinflammation. Exp. Neurol. 2014;253:102–110. doi: 10.1016/j.expneurol.2013.12.016.
    1. Liu S.B., Li Q., Zhang M.T., Mao-Ying Q.L., Hu L.Y., Wu G.C., Mi W.L., Wang Y.Q. Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1 beta via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling. Sci. Rep. 2016;6:28956. doi: 10.1038/srep28956.
    1. Zhu X.Y., Li Q., Chang R.M., Yang D., Song Z.B., Guo Q.L., Huang C.S. Curcumin alleviates neuropathic pain by inhibiting p300/CBP histone acetyltransferase activity-regulated expression of BDNF and Cox-2 in a rat model. PLoS ONE. 2014;9:e91303. doi: 10.1371/journal.pone.0091303.
    1. Dong W.W., Yang B., Wang L.L., Li B.X., Guo X.S., Zhang M., Jiang Z.F., Fu J.Q., Pi J.B., Guan D.W., et al. Curcumin plays neuroprotective roles against traumatic brain injury partly via nrf2 signaling. Toxicol. Appl. Pharmacol. 2018;346:28–36. doi: 10.1016/j.taap.2018.03.020.
    1. Huang L.F., Chen C.W., Zhang X., Li X., Chen Z.P., Yang C., Liang X.L., Zhu G.C., Xu Z. Neuroprotective effect of curcumin against cerebral ischemia-reperfusion via mediating autophagy and inflammation. J. Mol. Neurosci. 2018;64:129–139. doi: 10.1007/s12031-017-1006-x.
    1. Hu S.X., Maiti P., Ma Q.L., Zuo X.H., Jones M.R., Cole G.M., Frautschy S.A. Clinical development of curcumin in neurodegenerative disease. Expert Rev. Neurother. 2015;15:629–637. doi: 10.1586/14737175.2015.1044981.
    1. Liu Z.J., Li Z.H., Liu L., Tang W.X., Wang Y., Dong M.R., Xiao C. Curcumin attenuates beta-amyloid-induced neuroinflammation via activation of peroxisome proliferator-activated receptor-gamma function in a rat model of Alzheimer’s disease. Front. Pharmacol. 2016;7:261. doi: 10.3389/fphar.2016.00261.
    1. Wang Y.L., Li J.F., Wang Y.T., Xu C.Y., Hua L.L., Yang X.P., Geng S., Wang S.S., Wang Z., Yin H.L. Curcumin reduces hippocampal neuron apoptosis and JNK-3 phosphorylation in rats with A beta-induced Alzheimer’s disease: Protecting spatial learning and memory. J. Neurorestoratol. 2017;5:117–123. doi: 10.2147/JN.S125567.
    1. Huang H.C., Zheng B.W., Guo Y., Zhao J., Zhao J.Y., Ma X.W., Jiang Z.F. Antioxidative and neuroprotective effects of curcumin in an Alzheimer’s disease rat model co-treated with intracerebroventricular streptozotocin and subcutaneous D-galactose. J. Alzheimers Dis. 2016;52:899–911. doi: 10.3233/JAD-150872.
    1. Jiang T.F., Zhang Y.J., Zhou H.Y., Wang H.M., Tian L.P., Liu J., Ding J.Q., Chen S.D. Curcumin ameliorates the neurodegenerative pathology in A53T alpha-synuclein cell model of Parkinson’s disease through the downregulation of mTOR/p70s6K signaling and the recovery of macroautophagy. J. Neuroimmune Pharmacol. 2013;8:356–369. doi: 10.1007/s11481-012-9431-7.
    1. Sharma N., Nehru B. Curcumin affords neuroprotection and inhibits alpha-synuclein aggregation in lipopolysaccharide-induced Parkinson’s disease model. Inflammopharmacology. 2018;26:349–360. doi: 10.1007/s10787-017-0402-8.
    1. Khatri D.K., Jnvekar A.R. Neuroprotective effect of curcumin as evinced by abrogation of rotenone-induced motor deficits, oxidative and mitochondrial dysfunctions in mouse model of Parkinson’s disease. Pharmacol. Biochem. Behav. 2016;150:39–47. doi: 10.1016/j.pbb.2016.09.002.
    1. Meesarapee B., Thampithak A., Jaisin Y., Sanvarinda P., Suksamrarn A., Tuchinda P., Morales N.P., Sanvarinda Y. Curcumin I mediates neuroprotective effect through attenuation of quinoprotein formation, p-p38 MAPK expression, and caspase-3 activation in 6-hydroxydopamine treated SH-SY5Y cells. Phytother. Res. 2014;28:611–616. doi: 10.1002/ptr.5036.
    1. Abbaoui A., Chatoui H., El Hiba O., Gamrani H. Neuroprotective effect of curcumin-i in copper-induced dopaminergic neurotoxicity in rats: A possible link with Parkinson’s disease. Neurosci. Lett. 2017;660:103–108. doi: 10.1016/j.neulet.2017.09.032.
    1. Srivastava P., Yadav R.S., Chandravanshi L.P., Shukla R.K., Dhuriya Y.K., Chauhan L.K.S., Dwivedi H.N., Pant A.B., Khanna V.K. Unraveling the mechanism of neuroprotection of curcumin in arsenic induced cholinergic dysfunctions in rats. Toxicol. Appl. Pharmacol. 2014;279:428–440. doi: 10.1016/j.taap.2014.06.006.
    1. Agthong S., Kaewsema A., Charoensub T. Curcumin ameliorates functional and structural abnormalities in cisplatin-induced neuropathy. Exp. Neurobiol. 2015;24:139–145. doi: 10.5607/en.2015.24.2.139.
    1. Fan Y.L., Li H.C., Zhao W., Peng H.H., Huang F., Jiang W.H., Xu S.Y. Curcumin attenuated bupivacaine-induced neurotoxicity in SH-SY5Y cells via activation of the Akt signaling pathway. Neurochem. Res. 2016;41:2425–2432. doi: 10.1007/s11064-016-1955-4.
    1. Wang R., Tian S.Q., Yang X., Liu J.J., Wang Y.H., Sun K. Celecoxib-induced inhibition of neurogenesis in fetal frontal cortex is attenuated by curcumin via Wnt/beta-catenin pathway. Life Sci. 2017;185:95–102. doi: 10.1016/j.lfs.2017.07.028.
    1. Carmona-Ramirez I., Santamaria A., Tobon-Velasco J.C., Orozco-Ibarra M., Gonzalez-Herrera I.G., Pedraza-Chaverri J., Maldonado P.D. Curcumin restores Nrf2 levels and prevents quinolinic acid-induced neurotoxicity. J. Nutr. Biochem. 2013;24:14–24. doi: 10.1016/j.jnutbio.2011.12.010.
    1. Hernandez M., Wicz S., Corral R.S. Cardioprotective actions of curcumin on the pathogenic NFAT/COX-2/prostaglandin E-2 pathway induced during Trypanosoma cruzi infection. Phytomedicine. 2016;23:1392–1400. doi: 10.1016/j.phymed.2016.06.017.
    1. Yu W., Zha W.L., Ke Z.Q., Min Q., Li C.R., Sun H.R., Liu C. Curcumin protects neonatal rat cardiomyocytes against high glucose-induced apoptosis via PI3K/Akt signalling pathway. J. Diabetes Res. 2016;2016:4158591. doi: 10.1155/2016/4158591.
    1. Kohli S., Chhabra A., Jaiswal A., Rustagi Y., Sharma M., Rani V. Curcumin suppresses gelatinase B mediated norepinephrine induced stress in H9c2 cardiomyocytes. PLoS ONE. 2013;8:e76519. doi: 10.1371/journal.pone.0076519.
    1. Manghani C., Gupta A., Tripathi V., Rani V. Cardioprotective potential of curcumin against norepinephrine-induced cell death: A microscopic study. J. Microsc. 2017;265:232–244. doi: 10.1111/jmi.12492.
    1. Naserzadeh P., Mehr S.N., Sadabadi Z., Seydi E., Salimi A., Pourahmad J. Curcumin protects mitochondria and cardiomyocytes from oxidative damage and apoptosis induced by hemiscorpius lepturus venom. Drug Res. 2018;68:113–120. doi: 10.1055/s-0043-119073.
    1. Yang X.B., Jiang H., Shi Y. Upregulation of heme oxygenase-1 expression by curcumin conferring protection from hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblasts. Cell Biosci. 2017;7:523. doi: 10.1186/s13578-017-0146-6.
    1. Bai X.J., Hao J.T., Wang J., Zhang W.F., Yan C.P., Zhao J.H. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na+/Ca2+ exchanger expression after transverse abdominal aortic constriction in rats. Pharmacol. Rep. 2018;70:60–68. doi: 10.1016/j.pharep.2017.07.014.
    1. Chen R.C., Peng X.F., Du W.M., Wu Y., Huang B., Xue L., Wu Q., Qiu H.M., Jiang Q.S. Curcumin attenuates cardiomyocyte hypertrophy induced by high glucose and insulin via the PPAR gamma/Akt/NO signaling pathway. Diabetes Res. Clin. Pract. 2015;108:235–242. doi: 10.1016/j.diabres.2015.02.012.
    1. Katanasaka Y., Sunagawa Y., Hasegawa K., Morimoto T. Application of curcumin to heart failure therapy by targeting transcriptional pathway in cardiomyocytes. Biol. Pharm. Bull. 2013;36:13–17. doi: 10.1248/bpb.b212022.
    1. Cao Q., Zhang J.X., Gao L., Zhang Y.J., Dai M.Y., Bao M.W. Dickkopf-3 upregulation mediates the cardioprotective effects of curcumin on chronic heart failure. Mol. Med. Rep. 2018;17:7249–7257. doi: 10.3892/mmr.2018.8783.
    1. Feng D., Zou J., Zhang S.S., Li X.C., Lui M.Q. Hypocholesterolemic activity of curcumin is mediated by down-regulating the expression of Niemann-Pick C1-like 1 in hamsters. J. Agric. Food Chem. 2017;65:276–280. doi: 10.1021/acs.jafc.6b04102.
    1. Meng B., Li J., Cao H. Antioxidant and antiinflammatory activities of curcumin on diabetes mellitus and its complications. Curr. Pharm. Des. 2013;19:2101–2113.
    1. Chuengsamarn S., Rattanamongkolgul S., Luechapudiporn R., Phisalaphong C., Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care. 2012;35:2121–2127. doi: 10.2337/dc12-0116.
    1. Li J., Wang P.P., Ying J., Chen Z., Yu S.P. Curcumin attenuates retinal vascular leakage by inhibiting calcium/calmodulin-dependent protein kinase ii activity in streptozotocin-induced diabetes. Cell. Physiol. Biochem. 2016;39:1196–1208. doi: 10.1159/000447826.
    1. Li J., Wang P.P., Zhu Y.X., Chen Z., Shi T.Y., Lei W.S., Yu S.P. Curcumin inhibits neuronal loss in the retina and elevates Ca2+/calmodulin-dependent protein kinase II activity in diabetic rats. J. Ocul. Pharmacol. Ther. 2015;31:555–562. doi: 10.1089/jop.2015.0006.
    1. Wojcik M., Krawczyk M., Wojcik P., Cypryk K., Wozniak L.A. Molecular mechanisms underlying curcumin-mediated therapeutic effects in type 2 diabetes and cancer. Oxid. Med. Cell. Longev. 2018;2018:9698258. doi: 10.1155/2018/9698258.
    1. Jhong C.-H., Riyaphan J., Lin S.-H., Chia Y.-C., Weng C.-F. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico. BioFactors. 2015;41:242–251. doi: 10.1002/biof.1219.
    1. Akolade J.O., Oloyede H.O.B., Onyenekwe P.C. Encapsulation in chitosan-based polyelectrolyte complexes enhances antidiabetic activity of curcumin. J. Funct. Foods. 2017;35:584–594. doi: 10.1016/j.jff.2017.06.023.
    1. Gutierres V.O., Campos M.L., Arcaro C.A., Assis R.P., Baldan-Cimatti H.M., Peccinini R.G., Paula-Gomes S., Kettelhut I.C., Baviera A.M., Brunetti I.L. Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s) Evid. Based Complement. Alternat. Med. 2015;2015:678218. doi: 10.1155/2015/678218.
    1. Chanpoo M., Petchpiboonthai H., Panyarachun B., Anupunpisit V. Effect of curcumin in the amelioration of pancreatic islets in streptozotocin-induced diabetic mice. J. Med. Assoc. Thai. 2010;93(Suppl. 6):S152–S159.
    1. Ou J.L., Mizushina Y., Wang S.Y., Chuang D.Y., Nadar M., Hsu W.L. Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity. FEBS J. 2013;280:5829–5840. doi: 10.1111/febs.12503.
    1. Abdollahi M.F., Zandi M., Shokrollahi P., Ehsani M. Synthesis and characterization of curcumin segmented polyurethane with induced antiplatelet activity. J. Polym. Res. 2015;22:179. doi: 10.1007/s10965-015-0824-1.
    1. Haghighizad H., Touhidi A., Pourmotabbed A., Moradpour F., Nedaei S.E., Pourmotabbed T. Curcumin improves chronic stress induced potentiated seizure activity in experimental model of epilepsy. J. Neurol. Sci. Turk. 2017;34:76–85.
    1. Mantzorou M., Pavlidou E., Vasios G., Tsagalioti E., Giaginis C. Effects of curcumin consumption on human chronic diseases: A narrative review of the most recent clinical data. Phytother. Res. 2018;32:957–975. doi: 10.1002/ptr.6037.
    1. Bilia A.R., Bergonzi M.C., Isacchi B., Antiga E., Caproni M. Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels. J. Pharm. Pharmacol. 2018;70:919–928. doi: 10.1111/jphp.12910.
    1. Greil R., Greil-Ressler S., Weiss L., Schonlieb C., Magnes T., Radl B., Bolger G.T., Vcelar B., Sordillo P.P. A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (lipocurc((TM))) in patients with locally advanced or metastatic cancer. Cancer Chemother. Pharmacol. 2018;82:695–706. doi: 10.1007/s00280-018-3654-0.
    1. Jimenez-Osorio A.S., Garcia-Nino W.R., Gonzalez-Reyes S., Alvarez-Mejia A.E., Guerra-Leon S., Salazar-Segovia J., Falcon I., de Oca-Solano H.M., Madero M., Pedraza-Chaverri J. The effect of dietary supplementation with curcumin on redox status and Nrf2 activation in patients with nondiabetic or diabetic proteinuric chronic kidney disease: A pilot study. J. Renal Nutr. 2016;26:237–244. doi: 10.1053/j.jrn.2016.01.013.
    1. Amalraj A., Varma K., Jacob J., Divya C., Kunnumakkara A.B., Stohs S.J., Gopi S. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: A randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J. Med. Food. 2017;20:1022–1030. doi: 10.1089/jmf.2017.3930.
    1. Henrotin Y., Gharbi M., Dierckxsens Y., Priem F., Marty M., Seidel L., Albert A., Heuse E., Bonnet V., Castermans C. Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. BMC Complement. Altern. Med. 2014;14:159. doi: 10.1186/1472-6882-14-159.
    1. Antiga E., Bonciolini V., Volpi W., Del Bianco E., Caproni M. Oral curcumin (Meriva) is effective as an adjuvant treatment and is able to reduce IL-22 serum levels in patients with psoriasis vulgaris. BioMed Res. Int. 2015;2015:283634. doi: 10.1155/2015/283634.
    1. Abdolahi M., Sarraf P., Javanbakht M.H., Honarvar N.M., Hatami M., Soveyd N., Tafakhori A., Sedighiyan M., Djalali M., Jafarieh A., et al. A novel combination of omega-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity c-reactive protein serum levels in patients with migraine: A randomized clinical trial study. CNS Neurol. Disord. Drug Targets. 2018;17:430–438. doi: 10.2174/1871527317666180625101643.
    1. Kuriakose M.A., Ramdas K., Dey B., Iyer S., Rajan G., Elango K.K., Suresh A., Ravindran D., Kumar R.R., Prathiba R., et al. A randomized double-blind placebo-controlled phase iib trial of curcumin in oral leukoplakia. Cancer Prev. Res. 2016;9:683–691. doi: 10.1158/1940-6207.CAPR-15-0390.
    1. Duetzmann S., Schiborr C., Kocher A., Pilatus U., Hattingen E., Weissenberger J., Gessler F., Quick-Weller J., Franz K., Seifert V., et al. Intratumoral concentrations and effects of orally administered micellar curcuminoids in glioblastoma patients. Nutr. Cancer. 2016;68:943–948. doi: 10.1080/01635581.2016.1187281.
    1. Funamoto M., Sunagawa Y., Katanasaka Y., Miyazaki Y., Imaizumi A., Kakeya H., Yamakage H., Satoh-Asahara N., Komiyama M., Wada H., et al. Highly absorptive curcumin reduces serum atherosclerotic low-density lipoprotein levels in patients with mild copd. Int. J. Chron. Obstruct. Pulmon. Dis. 2016;11:2029–2034. doi: 10.2147/copd.s104490.
    1. Yang Y.S., Su Y.F., Yang H.W., Lee Y.H., Chou J.I., Ueng K.C. Lipid-lowering effects of curcumin in patients with metabolic syndrome: A randomized, double-blind, placebo-controlled trial. Phytother. Res. 2014;28:1770–1777. doi: 10.1002/ptr.5197.
    1. Chuengsamarn S., Rattanamongkolgul S., Phonrat B., Tungtrongchitr R., Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: A randomized controlled trial. J. Nutr. Biochem. 2014;25:144–150. doi: 10.1016/j.jnutbio.2013.09.013.
    1. Mirzabeigi P., Mohammadpour A.H., Salarifar M., Gholami K., Mojtahedzadeh M., Javadi M.R. The effect of curcumin on some of traditional and non-traditional cardiovascular risk factors: A pilot randomized, double-blind, placebo-controlled trial. Iran. J. Pharm. Res. 2015;14:479–486.
    1. Neerati P., Devde R., Gangi A.K. Evaluation of the effect of curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus. Phytother. Res. 2014;28:1796–1800. doi: 10.1002/ptr.5201.
    1. Rahimi H.R., Mohammadpour A.H., Dastani M., Jaafari M.R., Abnous K., Mobarhan M.G., Oskuee R.K. The effect of nano-curcumin on HBA1C, fasting blood glucose, and lipid profile in diabetic subjects: A randomized clinical trial. Avicenna J. Phytomed. 2016;6:567–577.
    1. Kunati S.R., Yang S.M., William B.M., Xu Y. An LC-MS/MS method for simultaneous determination of curcumin, curcumin glucuronide and curcumin sulfate in a phase II clinical trial. J. Pharm. Biomed. Anal. 2018;156:189–198. doi: 10.1016/j.jpba.2018.04.034.
    1. Adahoun M.A., Al-Akhras M.A.H., Jaafar M.S., Bououdina M. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles. Artif. Cells Nanomed. Biotechnol. 2017;45:98–107. doi: 10.3109/21691401.2015.1129628.
    1. Bai F., Diao J.J., Wang Y., Sun S.X., Zhang H.M., Liu Y.Y., Wang Y.Q., Cao J. A new water-soluble nanomicelle formed through self-assembly of pectin-curcumin conjugates: Preparation, characterization, and anticancer activity evaluation. J. Agric. Food Chem. 2017;65:6840–6847. doi: 10.1021/acs.jafc.7b02250.
    1. Khayyal M.T., El-Hazek R.M., El-Sabbagh W.A., Frank J., Behnam D., Abdel-Tawab M. Micellar solubilisation enhances the antiinflammatory activities of curcumin and boswellic acids in rats with adjuvant-induced arthritis. Nutrition. 2018;54:189–196. doi: 10.1016/j.nut.2018.03.055.
    1. Akbar M.U., Zia K.M., Nazir A., Iqbal J., Ejaz S.A., Akash M.S.H. Pluronic-based mixed polymeric micelles enhance the therapeutic potential of curcumin. AAPS PharmSciTech. 2018;19:2719–2739. doi: 10.1208/s12249-018-1098-9.
    1. Schiborr C., Kocher A., Behnam D., Jandasek J., Toelstede S., Frank J. The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol. Nutr. Food Res. 2014;58:516–527. doi: 10.1002/mnfr.201300724.
    1. Kocher A., Bohnert L., Schiborr C., Frank J. Highly bioavailable micellar curcuminoids accumulate in blood, are safe and do not reduce blood lipids and inflammation markers in moderately hyperlipidemic individuals. Mol. Nutr. Food Res. 2016;60:1555–1563. doi: 10.1002/mnfr.201501034.
    1. Li X., Chen T., Xu L., Zhang Z., Li L., Chen H. Preparation of curcumin micelles and the in vitro and in vivo evaluation for cancer therapy. J. Biomed. Nanotechnol. 2014;10:1458–1468. doi: 10.1166/jbn.2014.1840.
    1. Hagl S., Kocher A., Schiborr C., Kolesova N., Frank J., Eckert G.P. Curcumin micelles improve mitochondrial function in neuronal PC12 cells and brains of nmri mice–impact on bioavailability. Neurochem. Int. 2015;89:234–242. doi: 10.1016/j.neuint.2015.07.026.
    1. Baker M. Deceptive curcumin offers cautionary tale for chemists. Nature. 2017;541:144–145. doi: 10.1038/541144a.
    1. Bahadori F., Demiray M. A realistic view on “the essential medicinal chemistry of curcumin”. ACS Med. Chem. Lett. 2017;8:893–896. doi: 10.1021/acsmedchemlett.7b00284.
    1. Heger M. Drug screening: Don’t discount all curcumin trial data. Nature. 2017;543:40. doi: 10.1038/543040c.
    1. Jin T.R., Song Z.L., Weng J.P., Fantus I.G. Curcumin and other dietary polyphenols: Potential mechanisms of metabolic actions and therapy for diabetes and obesity. Am. J. Physiol. Endocrinol. Metab. 2018;314:E201–E205. doi: 10.1152/ajpendo.00285.2017.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する